Qubit Pharmaceuticals Receives Nomination for Best Start-Up 2024 Award
Qubit Pharmaceuticals, a deeptech company specializing in the discovery of new drug candidates through simulation and molecular modeling accelerated by hybrid HPC and quantum computing, has been nominated for the Prix Galien USA 'Best Startup Award'.
Pharmaceutical Research | 22/08/2024 | By Aishwarya
Selvita Acquires PozLab to Expand its Drug Development Capabilities
Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.
Pharmaceutical Research | 08/05/2024 | By Aishwarya | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy